Roche Holding AG (SWX:RO)
Switzerland
· Delayed Price · Currency is CHF 281.00
+1.80 (0.64%)
Apr 28, 2025, 10:45 AM CET
Roche Holding AG Revenue
In the year 2024, Roche Holding AG had annual revenue of 62.40B CHF with 3.23% growth. Roche Holding AG had revenue of 31.64B in the half year ending December 31, 2024, a decrease of -0.86%.
Revenue
62.40B
Revenue Growth
+3.23%
P/S Ratio
3.37
Revenue / Employee
604.32K
Employees
103,249
Market Cap
210.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 62.40B | 1.95B | 3.23% |
| Dec 31, 2023 | 60.44B | -5.37B | -8.16% |
| Dec 31, 2022 | 65.81B | -36.00M | -0.05% |
| Dec 31, 2021 | 65.85B | 5.51B | 9.13% |
| Dec 31, 2020 | 60.34B | -3.41B | -5.35% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 62.40B |
| Novartis AG | 46.87B |
| Lonza Group AG | 6.57B |
| Alcon | 8.98B |
| Galderma Group AG | 4.02B |
| Straumann Holding AG | 2.50B |
| Sandoz Group AG | 9.41B |
| Sonova Holding AG | 3.71B |
Roche Holding AG News
- 12 hours ago - 'Roche could've earned over 100 times what it cost for rare disease drug' - The Times of India
- 15 hours ago - Notable healthcare headlines for the week: Merck, Roche and Bausch Health in focus - Seeking Alpha
- 1 day ago - Zealand Pharma says obesity drug deal with Roche will help it stay independent - Financial Times
- 2 days ago - Roche: Key Products Stall, Obesity Pipeline Takes Shape - Seeking Alpha
- 3 days ago - New England Journal of Medicine publishes phase III data showing single-dose Xofluza significantly reduces influenza virus transmission - GlobeNewsWire
- 3 days ago - New England Journal of Medicine Publishes Phase III Data Showing Single-dose Xofluza Significantly Reduces Influenza Virus Transmission - Business Wire
- 3 days ago - Roche Holding AG (RHHBY) Q1 2025 Sales/ Trading Statement Call Transcript - Seeking Alpha
- 3 days ago - Pharma Giant Roche Tops First-Quarter Views; Sanofi's Sales Come In Mixed - Investor's Business Daily